Status:
UNKNOWN
Impact of Glycemic State on Patients ST Elevation Myocardial Infarction With Primary Percutaneous Coronary Angioplasty
Lead Sponsor:
Assiut University
Conditions:
ST Elevation Myocardial Infarction
Eligibility:
All Genders
Brief Summary
ST-elevation myocardial infarction is a major cause of morbidity and mortality worldwide. ST-elevation myocardial infarction damages the regional myocardium that undergoes ischemia and necrosis, resul...
Detailed Description
Reperfusion failure is attributed to different factors, including diabetes. Several mechanisms have been proposed for the harmful effects of hyperglycemia after acute myocardial infarction. Associatio...
Eligibility Criteria
Inclusion
- The study will be performed on acute ST-elevation myocardial infarction patients with/without history of diabetes mellitus undergoing primary percutaneous coronary intervention.
Exclusion
- Patients not treated with primary percutaneous coronary intervention.
- Patients with prior myocardial infarction, prior primary percutaneous coronary intervention and/or coronary artery bypass graft (altering disease state).
- Patients with cardiogenic shock (altering disease state).
- Patients with severe liver or renal disease (altering disease state).
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2019
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03266978
Start Date
January 1 2018
End Date
July 1 2019
Last Update
August 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University
Asyut, Egypt, 71111